Apheresis Market Share, Size, Growth, Opportunity and Forecast Till 2022-2031

The report predicts the global Apheresis Market to grow with a CAGR of 11.00% over the forecast period from 2022 to 2031.

Apheresis is a process in which the blood of a donor/patient is passed through a medical device, which separates one or more components of blood and returns the remaining with or without extracorporeal treatment or replacement of the separated components. This process involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. The global market was valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2031 growing at a CAGR of 11.0% from 2022 to 2031. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future.

This market is driven by the advantages of apheresis collection over whole blood collection, huge demand for plasma in plasma fractionation, and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market.

North America holds the largest market share of close to 50%, followed by Europe in 2012. In the next five years, emerging countries are estimated to register the highest growth rate, primarily due to increasing investments and huge demand for blood components from countries like China and India with a large populations.

Request The Sample PDF Report Here: https://www.sdki.jp/sample-request-59159

The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack.

Scope of the Report

The research report categorizes this market into the procedure, application, technology, product type, and end-user. All these markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011, and 2012, as well as forecast up to 2031. Each of the apheresis markets is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and the Rest of the World) to provide in-depth information on the global scenario.

Global Market segmentation:

By Procedure:
Donor Apheresis
Therapeutic Apheresis
Neurologic Disorders
Blood Disorders (TTP, Leukemia, & Others)
Renal Disease
Metabolic Disorders
Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others)

By Application:
Others (photopheresis, lipidpheresis, and Immunoadsoption)

By Technology:
Membrane Separation/Filtration

By Product type:

By End-user:
Blood banks/Blood collection centers
Hospitals & Hospital attached blood banks

Get The Sample PDF Report Here For More Insights: https://www.sdki.jp/sample-request-59159

By Geography:
North America
RoW (Rest of the World)

Each section of the report also provides market trends with respect to drivers, restraints, and opportunities. The report includes 13 company profiles and its competitive landscape section sketches the strategic developments in the market.

-Related Trending Reports:-

Optical Imaging Market Forecast 2022 To 2031

Medical Radiation Detection, Monitoring & Safety Market Forecast 2022 To 2031

Brain Monitoring Market Forecast 2022 To 2031

Cardiac Monitoring & Cardiac Rhythm Management (CRM) Market

Small Animal Imaging (In Vivo) Market

Leave a Reply

Your email address will not be published.